0
2023
Ventricular Assist Devices Market

Ventricular Assist Devices Market

by Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)), by Application (Bridge-To-Transplant (BTT), Destination Therapy, Bridge-To-Recovery (BTR), Bridge To Candidacy Therapy), by Design (Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices), by Age (Adults, Pediatrics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A01694
Feb 2023 | Pages: 316
Tables: 187
Charts: 59
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Ventricular Assist Devices Market Research, 2031

The global ventricular assist devices market size was valued at $1,338.53 million in 2021, and is projected to reach $2,880.66 million by 2031, growing at a CAGR of 7.9% from 2022 to 2031. Ventricular assist devices (VADs) also known as mechanical circulatory support are implanted in the heart to assist the heart's pumping action. Ventricular assist devices are highly efficient medical devices used in treatment of patients with severe heart failure. These devices are implanted in patients who are waiting for a heart transplant or for those who are not eligible for a heart transplant.

The COVID-19 outbreak had negative impact on the global ventricular assist devices market. The pandemic had significant effect on patients, including those who were waiting to be transplanted or the transplant recipients. These challenges regarding survival and safety also impacted the recovery teams, organ procurement organizations, and donors as well as the recipients. In addition, there was a decrease in number of surgeries during the pandemic due to reduction in number of patients visit to the hospitals for diagnosis and treatment of disease other than COVID-19.

Ventricular Assist Devices Market

Ventricular assist devices offers advantages such as helping improve the patient's quality of life, reduce symptoms of heart failure and prevent frequent hospitalization. There are several types of VADs including continuous-flow VADs and pulsatile-flow VADs, each with their own benefits and drawbacks. VADs are typically placed near the patient's heart and are connected to the heart through tubes or grafts which is powered by batteries which are externally worn or by a cable that is plugged into a power supply. Left ventricular assisted devices (LVADs) are the commonly used VADs that are implanted in the heart to assist the heart's pumping action in case of left ventricular failure. 

“The ventricular assist devices market was negatively impacted during the lockdown period owning decrease in patient visit to the hospitals for diagnosis of diseases other than COVID-19 and decreased government funding for cardiovascular disease treatment.”  

Historical Overview 

The market was analyzed qualitatively and quantitatively from 2016-2023. The ventricular assist devices market grew at a CAGR of around 11.8% during 2017-2023. Most of the growth during this period was derived from the Asia-Pacific owing to the improving health awareness, high population base in countries such as India and China, rising disposable incomes, as well as well-established presence of domestic companies in the region.  

Market Dynamics 

Major factors that drive the growth of ventricular assist devices market size include the increase in prevalence of heart failure cases around the globe, technological advancements in the field of ventricular assist devices and rise in awareness among the population about heart failure and its available treatment options. In addition, growth & innovations in the healthcare industry and a massive pool of patients with cardiovascular disease is also driving the ventricular assist devices market growth. Increase in prevalence of cardiovascular conditions such as heart failure along with increase in prevalence of other conditions which may lead to heart failure also increases the demand for VADs. 

Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries. 

The COVID-19 outbreak had negative impact on the global ventricular assist devices market share. The pandemic had significant effect on patients, including those who were waiting to be transplanted or the transplant recipients. These challenges regarding survival and safety also impacted the recovery teams, organ procurement organizations, and donors as well as the recipients. In addition, there was a decrease in number of surgeries during the pandemic due to reduction in number of patients visit to the hospitals for diagnosis and treatment of disease other than COVID-19. The reduction in patient visit was mainly attributed to the threat of being infected by corona virus infection and the shift of focus of healthcare sector toward COVID-19, which further negatively affected the ventricular assist devices market share. In addition, the government funding and drives regarding cardiovascular diseases were reduced due to increase in COVID- 19 funding, which further reduced the patients opting for heart failure treatment. 

Segmental Overview 

The ventricular assist devices market is segmented on the basis of product, application, design, age, and region. By product, the market is categorized into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). On the basis of application, the market is categorized into bridge-to-transplant (BTT), destination therapy, bridge-to-recovery (BTR), and bridge to candidacy therapy. On the basis of design, the market is bifurcated into transcutaneous ventricular assist devices and implantable ventricular assist devices. By age, the market is divided into adults and pediatrics. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Ventricular Assist Devices Market

By product the left ventricular assist devices (LVADs) segment dominated the global market in 2021, and is anticipated to grow at a fastest rate with a highest CAGR. This growth of the market is attributed to the advantages offered by left ventricular assist devices such as LVADs can significantly improve survival rates in patients with heart failure, prevents hospitalization and reduce the need for emergency room visits, can be used as a bridge to transplant helping patients who are waiting for a transplant to stay healthy.  

Ventricular Assist Devices Market

By application the bridge-to-transplant (BTT) segment dominated the global ventricular assist devices industry in 2021, owing to the rise in awareness among the people regarding bridge-to-transplant therapy in case of heart failure. On the other hand, destination therapy segment is anticipated to grow at a fastest rate during the ventricular assist devices market forecast period, due to the dearth in healthy heart donors. It significantly improve survival rates in patients with heart failure, and function as a valuable tool in the management of heart failure condition, which increases its demand in the market 

Ventricular Assist Devices Market

By design the implantable ventricular assist devices segment held the largest market share in 2021 and is expected to grow at a fastest rate during the forecast period, owing to the increase in prevalence of heart failure cases all-round the globe and rise in adoption of implantable ventricular assisted devices to improve the heart's pumping function, which can lead to a better quality of life for patients.  

Ventricular Assist Devices Market

By age the adult segment dominated the market in the year 2021, owing to the high demand for ventricular assist devices in the adults and the ageing population, due to greater prevalence of heart failure in adults. Lifestyle factors that increase the risk of heart attack and stroke such as smoking, obesity, bad eating habits and physical inactivity in adults can also lead to heart failure which boost the market growth. 

On the other hand, the pediatric segment is anticipated to dominate the market during the forecast period, owing to the increase in demand for pediatric mechanical circulatory support and due to the technological advancements in development of efficient pediatric VADs. 

Ventricular Assist Devices Market

By region the ventricular assist devices industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the ventricular assist devices market in 2021 and is expected to maintain its dominance during the forecast period. 

Presence of several major players, such as Abiomed, Inc., Bivacor Inc., Berlin Heart GmbH, NuPulseCV, Inc., Jarvik Heart, Inc., Windmill Cardiovascular Systems, Abbott Laboratories and others is driving the growth of the market in North America region. In addition, technological advancement in manufacturing of ventricular assist devices is leading to the increase in innovation in VADs and rises its adoption in North America. In addition, surge in demands for ventricular assisted devices owing to the rise in prevalence of heart failure in North America, is anticipated to drive the market. 

Furthermore, presence of well-established healthcare infrastructure, high purchasing power, and awareness about advanced technologies in healthcare field in people are expected to boost the market growth. The surge in awareness among the medical community about the advantages of ventricular assisted devices is further responsible to drive the market growth in this region. Growth of the market in U.S. is attributed to unhealthy lifestyle, which leads to cardiovascular disorders, and increase in geriatric population, which is highly susceptible to such abnormalities thereby increasing the demand for VADs.  

Asia-Pacific expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to presence of medical device companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Asia-Pacific offers profitable opportunities for key players operating in the ventricular assist devices market, thereby registering the fastest growth rate during the forecast period. Also, the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region is expected to boost the market during the forecast period.  

Competitive Analysis 

Competitive analysis and profiles of the major players in the ventricular assist devices, such as Abbott Laboratories, Abiomed, Inc., AdjuCor GmbH, Berlin Heart GmbH, Bivacor Inc., Calon Cardio-Technology Ltd, Carmat SA, CH Biomedical, Inc., Corewave SA, Evaheart, Inc., Fineheart, Jarvik Heart, Inc., LivaNova PLC, NuPulseCV, Inc., SynCardia Systems, LLC and Windmill Cardiovascular Systems are provided in this report. Major players have adopted product approval, expansion, new product development, product upgrade/development, agreement, clinical trials and acquisition as key developmental strategies to improve the product portfolio of the ventricular assist devices.  

Recent Approvals and Advancements in Ventricular Assist Devices Market

  • In June 2021, The Impella RP with SmartAssist, the newest right heart pump from Abiomed has been granted a pre-market approval (PMA) by the FDA as a safe and efficient treatment for acute right heart failure for up to 14 days. 
  • In September 2022, Abiomed announced two approvals from the U.S. Food and Drug Administration (FDA) related to clinical research of Impella heart pumps in acute myocardial infarction (AMI) cardiogenic shock patients. The FDA has approved the on-label RECOVER IV randomized controlled trial (RCT) for AMI cardiogenic shock patients. 
  • In May 2019, Abiomed announced the U.S. FDA has approval for the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic shock. 
  • In November 2021, CH Biomedical received approval for the implantable CH-VAD left ventricular assist system by the National Medical Products Administration (NMPA) for marketing in China. 

Acquisitions in the Ventricular Assist Devices Market  

  • In June 2021, Abiomed acquired preCARDIA, developer of a proprietary catheter and controller which will complement Abiomed’s product portfolio to expand options for patients with acute decompensated heart failure (ADHF). 
  • In December 2022, Abiomed, Inc. was acquired by Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.  

Product Development  

In September 2019, Abiomed announced that the first three patients in the world have been successfully treated with Impella RP Flex with SmartAssist, which is a newest heart pump for patients experiencing right heart failure.  

Clinical Trials of Ventricular Assist Devices Market

  • In October 2022, CARMAT announced that it has been granted the necessary regulatory approvals from the French National Agency for Medicine and Health Product Safety (ANSM) and the Patient Protection Committee to restart the EFICAS Clinical Study. 
  • In September 2021, CARMAT announced that it has received final approval from the Patient Protection Committee for the use of the commercial version of the Aeson heart in the EFICAS study in France. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ventricular assist devices market analysis from 2021 to 2031 to identify the prevailing ventricular assist devices market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ventricular assist devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ventricular assist devices market trends, key players, market segments, application areas, and market growth strategies.

Ventricular Assist Devices Market Report Highlights

Aspects Details
Market Size By 2031 USD 2.9 billion
Growth Rate CAGR of 7.9%
Forecast period 2021 - 2031
Report Pages 316
By Product
  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)
By Application
  • Bridge-To-Transplant (BTT)
  • Destination Therapy
  • Bridge-To-Recovery (BTR)
  • Bridge To Candidacy Therapy
By Design
  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices
By Age
  • Adults
  • Pediatrics
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Jarvik Heart, Inc., SynCardia Systems, LLC, AdjuCor GmbH, Berlin Heart GmbH, Evaheart, Inc., Corewave SA, Abbott Laboratories, LivaNova PLC, Carmat SA, Windmill Cardiovascular Systems, Calon Cardio-Technology Ltd, Abiomed, Inc., Bivacor Inc., NuPulseCV, Inc., CH Biomedical, Inc., Fineheart
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in incidence of heart failures
        • 3.4.1.2. Technological advancements
        • 3.4.1.3. Rise in patient awareness about heart failure treatment options
        • 3.4.1.4. Dearth of heart donors

      • 3.4.2. Restraints

        • 3.4.2.1. High cost of devices and procedures
        • 3.4.2.2. Serious risks involved in the procedure

      • 3.4.3. Opportunities

        • 3.4.3.1. Lucrative opportunities in the emerging markets

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Left Ventricular Assist Devices (LVADs)

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Right Ventricular Assist Devices (RVADs)

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Biventricular Assist Devices (BIVADs)

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

  • CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Bridge-To-Transplant (BTT)

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Destination Therapy

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Bridge-To-Recovery (BTR)

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Bridge To Candidacy Therapy

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

  • CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Transcutaneous Ventricular Assist Devices

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Implantable Ventricular Assist Devices

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE

    • 7.1. Overview

      • 7.1.1. Market size and forecast

    • 7.2. Adults

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by region

      • 7.2.3. Market share analysis by country

    • 7.3. Pediatrics

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by region

      • 7.3.3. Market share analysis by country

  • CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION

    • 8.1. Overview

      • 8.1.1. Market size and forecast By Region

    • 8.2. North America

      • 8.2.1. Key trends and opportunities

      • 8.2.2. Market size and forecast, by Product

      • 8.2.3. Market size and forecast, by Application

      • 8.2.4. Market size and forecast, by Design

      • 8.2.5. Market size and forecast, by Age

      • 8.2.6. Market size and forecast, by country

        • 8.2.6.1. U.S.
          • 8.2.6.1.1. Key market trends, growth factors and opportunities
          • 8.2.6.1.2. Market size and forecast, by Product
          • 8.2.6.1.3. Market size and forecast, by Application
          • 8.2.6.1.4. Market size and forecast, by Design
          • 8.2.6.1.5. Market size and forecast, by Age
        • 8.2.6.2. Canada
          • 8.2.6.2.1. Key market trends, growth factors and opportunities
          • 8.2.6.2.2. Market size and forecast, by Product
          • 8.2.6.2.3. Market size and forecast, by Application
          • 8.2.6.2.4. Market size and forecast, by Design
          • 8.2.6.2.5. Market size and forecast, by Age
        • 8.2.6.3. Mexico
          • 8.2.6.3.1. Key market trends, growth factors and opportunities
          • 8.2.6.3.2. Market size and forecast, by Product
          • 8.2.6.3.3. Market size and forecast, by Application
          • 8.2.6.3.4. Market size and forecast, by Design
          • 8.2.6.3.5. Market size and forecast, by Age
    • 8.3. Europe

      • 8.3.1. Key trends and opportunities

      • 8.3.2. Market size and forecast, by Product

      • 8.3.3. Market size and forecast, by Application

      • 8.3.4. Market size and forecast, by Design

      • 8.3.5. Market size and forecast, by Age

      • 8.3.6. Market size and forecast, by country

        • 8.3.6.1. Germany
          • 8.3.6.1.1. Key market trends, growth factors and opportunities
          • 8.3.6.1.2. Market size and forecast, by Product
          • 8.3.6.1.3. Market size and forecast, by Application
          • 8.3.6.1.4. Market size and forecast, by Design
          • 8.3.6.1.5. Market size and forecast, by Age
        • 8.3.6.2. France
          • 8.3.6.2.1. Key market trends, growth factors and opportunities
          • 8.3.6.2.2. Market size and forecast, by Product
          • 8.3.6.2.3. Market size and forecast, by Application
          • 8.3.6.2.4. Market size and forecast, by Design
          • 8.3.6.2.5. Market size and forecast, by Age
        • 8.3.6.3. UK
          • 8.3.6.3.1. Key market trends, growth factors and opportunities
          • 8.3.6.3.2. Market size and forecast, by Product
          • 8.3.6.3.3. Market size and forecast, by Application
          • 8.3.6.3.4. Market size and forecast, by Design
          • 8.3.6.3.5. Market size and forecast, by Age
        • 8.3.6.4. Italy
          • 8.3.6.4.1. Key market trends, growth factors and opportunities
          • 8.3.6.4.2. Market size and forecast, by Product
          • 8.3.6.4.3. Market size and forecast, by Application
          • 8.3.6.4.4. Market size and forecast, by Design
          • 8.3.6.4.5. Market size and forecast, by Age
        • 8.3.6.5. Spain
          • 8.3.6.5.1. Key market trends, growth factors and opportunities
          • 8.3.6.5.2. Market size and forecast, by Product
          • 8.3.6.5.3. Market size and forecast, by Application
          • 8.3.6.5.4. Market size and forecast, by Design
          • 8.3.6.5.5. Market size and forecast, by Age
        • 8.3.6.6. Rest of Europe
          • 8.3.6.6.1. Key market trends, growth factors and opportunities
          • 8.3.6.6.2. Market size and forecast, by Product
          • 8.3.6.6.3. Market size and forecast, by Application
          • 8.3.6.6.4. Market size and forecast, by Design
          • 8.3.6.6.5. Market size and forecast, by Age
    • 8.4. Asia-Pacific

      • 8.4.1. Key trends and opportunities

      • 8.4.2. Market size and forecast, by Product

      • 8.4.3. Market size and forecast, by Application

      • 8.4.4. Market size and forecast, by Design

      • 8.4.5. Market size and forecast, by Age

      • 8.4.6. Market size and forecast, by country

        • 8.4.6.1. Japan
          • 8.4.6.1.1. Key market trends, growth factors and opportunities
          • 8.4.6.1.2. Market size and forecast, by Product
          • 8.4.6.1.3. Market size and forecast, by Application
          • 8.4.6.1.4. Market size and forecast, by Design
          • 8.4.6.1.5. Market size and forecast, by Age
        • 8.4.6.2. China
          • 8.4.6.2.1. Key market trends, growth factors and opportunities
          • 8.4.6.2.2. Market size and forecast, by Product
          • 8.4.6.2.3. Market size and forecast, by Application
          • 8.4.6.2.4. Market size and forecast, by Design
          • 8.4.6.2.5. Market size and forecast, by Age
        • 8.4.6.3. Australia
          • 8.4.6.3.1. Key market trends, growth factors and opportunities
          • 8.4.6.3.2. Market size and forecast, by Product
          • 8.4.6.3.3. Market size and forecast, by Application
          • 8.4.6.3.4. Market size and forecast, by Design
          • 8.4.6.3.5. Market size and forecast, by Age
        • 8.4.6.4. India
          • 8.4.6.4.1. Key market trends, growth factors and opportunities
          • 8.4.6.4.2. Market size and forecast, by Product
          • 8.4.6.4.3. Market size and forecast, by Application
          • 8.4.6.4.4. Market size and forecast, by Design
          • 8.4.6.4.5. Market size and forecast, by Age
        • 8.4.6.5. South Korea
          • 8.4.6.5.1. Key market trends, growth factors and opportunities
          • 8.4.6.5.2. Market size and forecast, by Product
          • 8.4.6.5.3. Market size and forecast, by Application
          • 8.4.6.5.4. Market size and forecast, by Design
          • 8.4.6.5.5. Market size and forecast, by Age
        • 8.4.6.6. Rest of Asia-Pacific
          • 8.4.6.6.1. Key market trends, growth factors and opportunities
          • 8.4.6.6.2. Market size and forecast, by Product
          • 8.4.6.6.3. Market size and forecast, by Application
          • 8.4.6.6.4. Market size and forecast, by Design
          • 8.4.6.6.5. Market size and forecast, by Age
    • 8.5. LAMEA

      • 8.5.1. Key trends and opportunities

      • 8.5.2. Market size and forecast, by Product

      • 8.5.3. Market size and forecast, by Application

      • 8.5.4. Market size and forecast, by Design

      • 8.5.5. Market size and forecast, by Age

      • 8.5.6. Market size and forecast, by country

        • 8.5.6.1. Brazil
          • 8.5.6.1.1. Key market trends, growth factors and opportunities
          • 8.5.6.1.2. Market size and forecast, by Product
          • 8.5.6.1.3. Market size and forecast, by Application
          • 8.5.6.1.4. Market size and forecast, by Design
          • 8.5.6.1.5. Market size and forecast, by Age
        • 8.5.6.2. Saudi Arabia
          • 8.5.6.2.1. Key market trends, growth factors and opportunities
          • 8.5.6.2.2. Market size and forecast, by Product
          • 8.5.6.2.3. Market size and forecast, by Application
          • 8.5.6.2.4. Market size and forecast, by Design
          • 8.5.6.2.5. Market size and forecast, by Age
        • 8.5.6.3. South Africa
          • 8.5.6.3.1. Key market trends, growth factors and opportunities
          • 8.5.6.3.2. Market size and forecast, by Product
          • 8.5.6.3.3. Market size and forecast, by Application
          • 8.5.6.3.4. Market size and forecast, by Design
          • 8.5.6.3.5. Market size and forecast, by Age
        • 8.5.6.4. Rest of LAMEA
          • 8.5.6.4.1. Key market trends, growth factors and opportunities
          • 8.5.6.4.2. Market size and forecast, by Product
          • 8.5.6.4.3. Market size and forecast, by Application
          • 8.5.6.4.4. Market size and forecast, by Design
          • 8.5.6.4.5. Market size and forecast, by Age
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top player positioning, 2021

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Evaheart, Inc.

      • 10.1.1. Company overview

      • 10.1.2. Key Executives

      • 10.1.3. Company snapshot

      • 10.1.4. Operating business segments

      • 10.1.5. Product portfolio

      • 10.1.6. Key strategic moves and developments

    • 10.2. Calon Cardio-Technology Ltd

      • 10.2.1. Company overview

      • 10.2.2. Key Executives

      • 10.2.3. Company snapshot

      • 10.2.4. Operating business segments

      • 10.2.5. Product portfolio

    • 10.3. Carmat SA

      • 10.3.1. Company overview

      • 10.3.2. Key Executives

      • 10.3.3. Company snapshot

      • 10.3.4. Operating business segments

      • 10.3.5. Product portfolio

      • 10.3.6. Key strategic moves and developments

    • 10.4. Fineheart

      • 10.4.1. Company overview

      • 10.4.2. Key Executives

      • 10.4.3. Company snapshot

      • 10.4.4. Operating business segments

      • 10.4.5. Product portfolio

      • 10.4.6. Key strategic moves and developments

    • 10.5. AdjuCor GmbH

      • 10.5.1. Company overview

      • 10.5.2. Key Executives

      • 10.5.3. Company snapshot

      • 10.5.4. Operating business segments

      • 10.5.5. Product portfolio

    • 10.6. Corewave SA

      • 10.6.1. Company overview

      • 10.6.2. Key Executives

      • 10.6.3. Company snapshot

      • 10.6.4. Operating business segments

      • 10.6.5. Product portfolio

      • 10.6.6. Key strategic moves and developments

    • 10.7. Bivacor Inc.

      • 10.7.1. Company overview

      • 10.7.2. Key Executives

      • 10.7.3. Company snapshot

      • 10.7.4. Operating business segments

      • 10.7.5. Product portfolio

      • 10.7.6. Key strategic moves and developments

    • 10.8. Windmill Cardiovascular Systems

      • 10.8.1. Company overview

      • 10.8.2. Key Executives

      • 10.8.3. Company snapshot

      • 10.8.4. Operating business segments

      • 10.8.5. Product portfolio

    • 10.9. NuPulseCV, Inc.

      • 10.9.1. Company overview

      • 10.9.2. Key Executives

      • 10.9.3. Company snapshot

      • 10.9.4. Operating business segments

      • 10.9.5. Product portfolio

    • 10.10. Abiomed, Inc.

      • 10.10.1. Company overview

      • 10.10.2. Key Executives

      • 10.10.3. Company snapshot

      • 10.10.4. Operating business segments

      • 10.10.5. Product portfolio

      • 10.10.6. Business performance

      • 10.10.7. Key strategic moves and developments

    • 10.11. LivaNova PLC

      • 10.11.1. Company overview

      • 10.11.2. Key Executives

      • 10.11.3. Company snapshot

      • 10.11.4. Operating business segments

      • 10.11.5. Product portfolio

      • 10.11.6. Business performance

      • 10.11.7. Key strategic moves and developments

    • 10.12. Berlin Heart GmbH

      • 10.12.1. Company overview

      • 10.12.2. Key Executives

      • 10.12.3. Company snapshot

      • 10.12.4. Operating business segments

      • 10.12.5. Product portfolio

      • 10.12.6. Key strategic moves and developments

    • 10.13. Jarvik Heart, Inc.

      • 10.13.1. Company overview

      • 10.13.2. Key Executives

      • 10.13.3. Company snapshot

      • 10.13.4. Operating business segments

      • 10.13.5. Product portfolio

    • 10.14. Abbott Laboratories

      • 10.14.1. Company overview

      • 10.14.2. Key Executives

      • 10.14.3. Company snapshot

      • 10.14.4. Operating business segments

      • 10.14.5. Product portfolio

      • 10.14.6. Business performance

      • 10.14.7. Key strategic moves and developments

    • 10.15. SynCardia Systems, LLC

      • 10.15.1. Company overview

      • 10.15.2. Key Executives

      • 10.15.3. Company snapshot

      • 10.15.4. Operating business segments

      • 10.15.5. Product portfolio

      • 10.15.6. Key strategic moves and developments

    • 10.16. CH Biomedical, Inc.

      • 10.16.1. Company overview

      • 10.16.2. Key Executives

      • 10.16.3. Company snapshot

      • 10.16.4. Operating business segments

      • 10.16.5. Product portfolio

      • 10.16.6. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
    TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
    TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
    TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
    TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
    TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
    TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
    TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
    TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
    TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
    TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
    TABLE 117. EVAHEART, INC.: KEY STRATERGIES
    TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
    TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
    TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
    TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
    TABLE 122. CARMAT SA: KEY EXECUTIVES
    TABLE 123. CARMAT SA: COMPANY SNAPSHOT
    TABLE 124. CARMAT SA: PRODUCT SEGMENTS
    TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
    TABLE 126. CARMAT SA: KEY STRATERGIES
    TABLE 127. FINEHEART: KEY EXECUTIVES
    TABLE 128. FINEHEART: COMPANY SNAPSHOT
    TABLE 129. FINEHEART: PRODUCT SEGMENTS
    TABLE 130. FINEHEART: PRODUCT PORTFOLIO
    TABLE 131. FINEHEART: KEY STRATERGIES
    TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
    TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
    TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
    TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
    TABLE 136. COREWAVE SA: KEY EXECUTIVES
    TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
    TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
    TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
    TABLE 140. COREWAVE SA: KEY STRATERGIES
    TABLE 141. BIVACOR INC.: KEY EXECUTIVES
    TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
    TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
    TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
    TABLE 145. BIVACOR INC.: KEY STRATERGIES
    TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
    TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
    TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
    TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
    TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
    TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
    TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
    TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
    TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
    TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
    TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
    TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
    TABLE 158. ABIOMED, INC.: KEY STRATERGIES
    TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
    TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
    TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
    TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
    TABLE 163. LIVANOVA PLC: KEY STRATERGIES
    TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
    TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
    TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
    TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
    TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
    TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
    TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
    TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
    TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
    TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
    TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
    TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
    TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
    TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
    TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
    TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
    TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
    TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
    TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
    TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
    TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 01. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN VENTRICULAR ASSIST DEVICES MARKET (2022-2031)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. LOW BARGAINING POWER OF BUYERS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW THREAT OF NEW ENTRANTS
    FIGURE 08. LOW INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALVENTRICULAR ASSIST DEVICES MARKET
    FIGURE 10. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY COUNTRY 2021-2031(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY COUNTRY 2021-2031(%)
    FIGURE 14. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY COUNTRY 2021-2031(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY COUNTRY 2021-2031(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY COUNTRY 2021-2031(%)
    FIGURE 19. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
    FIGURE 22. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY COUNTRY 2021-2031(%)
    FIGURE 24. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY COUNTRY 2021-2031(%)
    FIGURE 25. VENTRICULAR ASSIST DEVICES MARKET BY REGION, 2021
    FIGURE 26. U.S. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 28. MEXICO VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 29. GERMANY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 30. FRANCE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 31. UK VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 32. ITALY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 33. SPAIN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 34. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 35. JAPAN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 36. CHINA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 37. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 38. INDIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 39. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 40. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 41. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 42. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 43. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 44. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 49. COMPETITIVE DASHBOARD
    FIGURE 50. COMPETITIVE HEATMAP: VENTRICULAR ASSIST DEVICES MARKET
    FIGURE 51. TOP PLAYER POSITIONING, 2021
    FIGURE 52. ABIOMED, INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 53. ABIOMED, INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 54. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 55. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 56. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 57. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
    FIGURE 58. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)

 
 

This section provides opinions of top level CXOs in the global ventricular assist devices market. According to the insights of CXOs, the increase in demand for advanced treatment procedures for cardiovascular diseases is expected to offer profitable opportunities for the expansion of the market. Increase in demand for ventricular assist devices among heart failure patients is driving the growth of the ventricular assist devices market.

Furthermore, technological advancements in ventricular assist devices contribute to the expansion of the market. CXOs further added that rise in incidences of heart failure in population of both developed and developing regions largely contributed to generating market revenue in 2021 and is expected to maintain this trend during the forecast period. In addition, increase in awareness among the population regarding ventricular assist devices as a treatment option for heart failure and its advantages boosts its demand in the healthcare sector. Moreover, rise in funding and reimbursements for ventricular assist device (VAD) implantation offered by government and other organizations around the globe boosts the growth of market.

Furthermore, North America is expected to witness highest growth, in terms of revenue owing to high prevalence of cardiovascular disorders in the region along with increase in awareness among the population regarding VADs. However, Asia-Pacific is anticipated to witness notable growth, owing to surge in investments for manufacturing of ventricular assist devices, high population base, and upsurge in healthcare expenditure in emerging economies such as India and China.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The upcoming trends are key market players are investing on a large scale for the R&D activities related to ventricular assist devices. Companies are focusing on innovation to develop advanced ventricular assist devices that can overcome the drawbacks of the existing VADs. Moreover, large number of clinical and developmental studies are carried out to prove the efficiency of the devices, and to get the approval for the same. This is anticipated to drive the market expansion during the forecast period.

A. Bridge-to-transplant (BTT) is the leading application of Ventricular Assist Devices Market.

A. North America is the largest regional market for Ventricular Assist Devices.

A. The ventricular assist devices market valued for $1,338.53 million in 2021 and is estimated to reach $2,880.66 million by 2031, exhibiting a CAGR of 7.9% from 2022 to 2031.

A. Major Key players that operate in the global ventricular assist devices market are Abbott Laboratories, Abiomed, Inc., AdjuCor GmbH, Berlin Heart GmbH, Bivacor Inc., Calon Cardio-Technology Ltd, Carmat SA, CH Biomedical, Inc., Corewave SA, Evaheart, Inc., Fineheart, Jarvik Heart, Inc., LivaNova PLC, NuPulseCV, Inc., SynCardia Systems, LLC, and Windmill Cardiovascular Systems.

A. Yes, the Ventricular Assist Devices market report provides PORTER Analysis

A. The base year is 2021 in Ventricular Assist Devices market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Ventricular Assist Devices Market

Start reading instantly.
This Report and over 67,518+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2024 - Feb 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers